Can-Fite Biopharma Ltd CANF
2.16
(0.01)
(0.46%)
as of 25 Sep
- Market cap
- $6.5M
- P/E
- 0.0×
Follow CANF
| Jun '26 | Jun '25 | Jun '24 | Sep '23 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | (140.94%) |
+8 more TTM periods Free account |
|
| 0.00% | 0.00% | 0.00% | (81.58%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | (129.29%) | |
Average Days of Receivables |
— | — | — | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(19.15) | (19.92) | (18.64) | — | |
Capital Expenditures |
(0.01) | (0.01) | (0.02) | — | |
| Other line items | |||||
Cash ROIC |
(160.93%) | (187.13%) | (258.44%) | 0.00% | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 915.12% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 390.01% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
6.60 | 7.60 | 0.72 | 0.00 | |
Capex/Depreciation |
(0.24) | (0.32) | (0.83) | — | |
Revenue per Share |
— | — | — | 0.17 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
— | — | — | (1,148.62%) |
Columns are period end dates